BLTE
Belite Bio Inc ADR
NASDAQ: BLTE · HEALTHCARE · BIOTECHNOLOGY
$154.50
-2.66% today
Updated 2026-04-29
Market cap
$6.17B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.32
Dividend yield
—
52W range
$56 – $200
Volume
0.2M
Belite Bio Inc ADR (BLTE) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-16.90%
ROA
-11.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-5.75M | — | — | — |
| 2021 | $0.00 | $-9.67M | — | — | — |
| 2022 | $0.00 | $-12.65M | — | — | — |
| 2023 | $0.00 | $-31.63M | — | — | — |
| 2024 | $0.00 | $-36.14M | — | — | — |
| 2025 | $0.00 | $-77.61M | — | — | — |